Lorazepam in childhood status epilepticus and serial seizures: Effectiveness and tachyphylaxis

Thomas Owen Crawford, Wendy G. Mitchell, S. Robert Snodgrass

Research output: Contribution to journalArticle

Abstract

We report our experience with 300 consecutive parenteral doses of lorazepam (LOR) for status epilepticus (SE) or serial seizures in 77 children and young adults. The median dose for SE in children less than 12 years old was 0.10 mg/kg. LOR stopped the SE in 79% and diminished the intensity of SE in an additional 4%. Prior acute or chronic anticonvulsant use (excepting chronic benzodiazepines) did not alter effectiveness or increase side effects. Duration of freedom from seizures following acute therapy was independent of LOR dosage. In patients requiring sequential doses, LOR becomes progressively less effective. Side effects were few and, when present, always associated with a single or first dose in a series. LOR is a safe and effective acute anticonvulsant agent for in-hospital control of SE in the pediatric age group. Tachyphylaxis of anticonvulsant action occurs when serial doses are used.

Original languageEnglish (US)
Pages (from-to)190-195
Number of pages6
JournalNeurology
Volume37
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Tachyphylaxis
Lorazepam
Status Epilepticus
Seizures
Anticonvulsants
Benzodiazepines
Young Adult
Age Groups
Dose
Childhood
Pediatrics

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Lorazepam in childhood status epilepticus and serial seizures : Effectiveness and tachyphylaxis. / Crawford, Thomas Owen; Mitchell, Wendy G.; Snodgrass, S. Robert.

In: Neurology, Vol. 37, No. 2, 1987, p. 190-195.

Research output: Contribution to journalArticle

Crawford, Thomas Owen ; Mitchell, Wendy G. ; Snodgrass, S. Robert. / Lorazepam in childhood status epilepticus and serial seizures : Effectiveness and tachyphylaxis. In: Neurology. 1987 ; Vol. 37, No. 2. pp. 190-195.
@article{89d6939cf1c24169b5f8092085e3c725,
title = "Lorazepam in childhood status epilepticus and serial seizures: Effectiveness and tachyphylaxis",
abstract = "We report our experience with 300 consecutive parenteral doses of lorazepam (LOR) for status epilepticus (SE) or serial seizures in 77 children and young adults. The median dose for SE in children less than 12 years old was 0.10 mg/kg. LOR stopped the SE in 79{\%} and diminished the intensity of SE in an additional 4{\%}. Prior acute or chronic anticonvulsant use (excepting chronic benzodiazepines) did not alter effectiveness or increase side effects. Duration of freedom from seizures following acute therapy was independent of LOR dosage. In patients requiring sequential doses, LOR becomes progressively less effective. Side effects were few and, when present, always associated with a single or first dose in a series. LOR is a safe and effective acute anticonvulsant agent for in-hospital control of SE in the pediatric age group. Tachyphylaxis of anticonvulsant action occurs when serial doses are used.",
author = "Crawford, {Thomas Owen} and Mitchell, {Wendy G.} and Snodgrass, {S. Robert}",
year = "1987",
language = "English (US)",
volume = "37",
pages = "190--195",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Lorazepam in childhood status epilepticus and serial seizures

T2 - Effectiveness and tachyphylaxis

AU - Crawford, Thomas Owen

AU - Mitchell, Wendy G.

AU - Snodgrass, S. Robert

PY - 1987

Y1 - 1987

N2 - We report our experience with 300 consecutive parenteral doses of lorazepam (LOR) for status epilepticus (SE) or serial seizures in 77 children and young adults. The median dose for SE in children less than 12 years old was 0.10 mg/kg. LOR stopped the SE in 79% and diminished the intensity of SE in an additional 4%. Prior acute or chronic anticonvulsant use (excepting chronic benzodiazepines) did not alter effectiveness or increase side effects. Duration of freedom from seizures following acute therapy was independent of LOR dosage. In patients requiring sequential doses, LOR becomes progressively less effective. Side effects were few and, when present, always associated with a single or first dose in a series. LOR is a safe and effective acute anticonvulsant agent for in-hospital control of SE in the pediatric age group. Tachyphylaxis of anticonvulsant action occurs when serial doses are used.

AB - We report our experience with 300 consecutive parenteral doses of lorazepam (LOR) for status epilepticus (SE) or serial seizures in 77 children and young adults. The median dose for SE in children less than 12 years old was 0.10 mg/kg. LOR stopped the SE in 79% and diminished the intensity of SE in an additional 4%. Prior acute or chronic anticonvulsant use (excepting chronic benzodiazepines) did not alter effectiveness or increase side effects. Duration of freedom from seizures following acute therapy was independent of LOR dosage. In patients requiring sequential doses, LOR becomes progressively less effective. Side effects were few and, when present, always associated with a single or first dose in a series. LOR is a safe and effective acute anticonvulsant agent for in-hospital control of SE in the pediatric age group. Tachyphylaxis of anticonvulsant action occurs when serial doses are used.

UR - http://www.scopus.com/inward/record.url?scp=0023125613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023125613&partnerID=8YFLogxK

M3 - Article

C2 - 3808299

AN - SCOPUS:0023125613

VL - 37

SP - 190

EP - 195

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -